healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Protocols
therapy-injection-hylan-g-f20-three-weekly-dose-specific-generic
Outcomes
01
safety-adverse-reactions-injection-site-hematoma-pain-arthralgia-swelling-occurrence-binary-measured
1 evidence row
pavelka_2011_rct_efficacy-evaluation-of-highly-purified-intra-articular-hyaluronic-acid-sinovial-vs-hylan-g-f20-synvisc-in-the-treatment-of-symptomatic-knee-osteoarthritis-a-double-blind-controlled-randomized-parallel-group-non-inferiority-study
02
safety-serious-adverse-events-count-cohort-measured
1 evidence row
pavelka_2011_rct_efficacy-evaluation-of-highly-purified-intra-articular-hyaluronic-acid-sinovial-vs-hylan-g-f20-synvisc-in-the-treatment-of-symptomatic-knee-osteoarthritis-a-double-blind-controlled-randomized-parallel-group-non-inferiority-study
healthprotocol.wiki